ASBIS is a company that is committed to shaping the future through technology. In addition to its core business activities, it also supports startups that share the same purpose. In late 2021, ASBIS invested in EMBIO Diagnostics, a startup that offers innovative solutions for the rapid detection of bacteria and chemicals. This year, EMBIO Diagnostics was recognized for its efforts and was listed in the Foodtech 500. This is the world's first definitive list of global talent at the intersection of food, technology, and sustainability.
EMBIO Diagnostics is an incredible biotech company that specializes in designing and developing innovative, portable, biosensor-based digital devices that can detect bacteria and chemicals rapidly. One of the unique features of these devices is their integration with complex algorithms, AI, and machine learning, making them widely applicable in various sectors, including environmental, food safety, maritime, and medical sectors. ASBIS and EMBIO Diagnostics are proud of the impact that their innovation is having, and they are committed to continuing their work to build a brighter future for all.
